| Net income | 574.4M |
| Depreciation and amortization | 481.8M |
| Other non-cash adjustments to net income | |
| Changes in operating assets and liabilities | |
| Net cash provided by operating activities | 655.3M |
| Capital expenditures | -451.5M |
| Purchase of short-term investments | |
| Proceeds from sales of short-term investments | |
| Purchase of restricted investments | -36.1M |
| Proceeds from sales of restricted investments | 118.1M |
| Other | |
| Net cash used in investing activities | -368.3M |
| Payments for share repurchases | |
| Proceeds from stock issued pursuant to stock-based compensation plan | 33.3M |
| Tax benefit of stock-based compensation | 0 |
| Other | |
| Net cash used in financing activities | -290M |
| Effect of exchange rate changes on cash and cash equivalents | 700K |
| Net increase(decrease) in cash and cash equivalents | -2.3M |
| Cash and cash equivalents at beginning of period | 736.1M |
| Cash and cash equivalents at end of period | 733.8M |
| Interest | 302.8M |
| Income taxes | 399.1M |